monoclonal antibody
Document de presse
2021.05.12
Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed...
News
2021.05.03
Free et Self-paced
Emerging and re-emerging viruses are key players among the different pathogens that have caused recent epidemics, as attested by several...
News
2021.03.30
Since the beginning of the COVID-19 pandemic, and increasingly rapidly thereafter, the Institut Pasteur International Network has drawn heavily on all its...
Document de presse
2021.03.26
The B.1.1.7 and B.1.351 variants of SARS-CoV-2 were first detected in the UK and South Africa respectively, and have since spread to many other countries....
News
2021.03.11
Two projects have been accepted into the Institut Pasteur Innovation Accelerator, an initiative to improve the development potential of the Institut Pasteur's...
News
2021.01.20
Diarrheal diseases are the world's second leading cause of death in children aged under 5 years, and of these, bacillary dysentery or shigellosis remains a...
News
2020.11.24
«Pasteur Network Talent Awards» 2020 were presented on Thursday 19 November 2020 to Dr Sophie Valkenburg and Dr Roman Thibeaux by Pr Pierre-Marie Girard,...
Document de presse
2021.01.19
Scientists from the Institut Pasteur-TheraVectys Joint Laboratory recently published in Cell Host & Microbe1 the results of tests, in two preclinical...
Document de presse
2020.04.24
Approximately four months after the initial description of cases of atypical pneumonia in Wuhan, China, in December 2019, COVID-19 had become a major pandemic...
Document de presse
2020.08.12
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of...